Biological mitral valve restenosis after replacement in rheumatic heart disease is a rare complication. This case illustrates venoarterial extracorporeal membrane oxygenation to facilitate transcatheter mitral valve replacement in a patient with suprasystemic pulmonary pressure and cardiogenic shock with multiorgan failure secondary to critical mitral stenosis of a bioprosthetic valve.

JACC Editor-in-Chief 
Julia Grapsa, MD, PhD, FACC

CME Editor 
Nadeen N. Faza, MD, FACC

Authors
Assi Milwidsky, MD
Sharon Bruoha, MD
Rachel Clark, MD
Azeem Latib, MD
Ulrich Jorde, MD

Important Dates

Date of Release: April 6, 2022
Term of Approval/Date of CME/MOC/ECME Expiration: April 5 2023